German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.
Operation Silver Axe focused on ports and airports | Fake pesticides “harm farmers and their livelihoods” | Proliferation of counterfeits “deeply concerning” | EUIPO | Europol.
Localised production of pharmaceutical products at issue | First-ever WTO appeal of its kind settled by arbitration
Operation Pangea targeted illicit online pharmacies in 94 countries | erectile dysfunction medicines among items seized
The pair are rapped for overcharging the NHS | Unfair prices for an epilepsy drug lasted four years | Costs leapt from £2m to £50m in one year after the companies' “illegal exploitation” of market position.
Global industry body launches declaration | Poorer nations could benefit from more equitable vaccine access | Proposal to be tabled among G7 and G20.
California company resolves pay-for-delay issue over opioids | Allegations were brought by direct purchasers eight years ago.
Japan-based pharma company must pay for infringment | Drug was recently approved for breast cancer treatment by EU.
New partner boosts firm’s biotech practice | Move forms part of life sciences expansion | Role based at Washington, DC office.
Kidney test patents detect “natural phenomena” | Delaware court grants Natera and Eurofins summary judgments on ineligibility.